Want to create an interactive transcript for this episode?
Podcast: Keeping Current
Episode: The Evolution of Incretins – A Revolution in Diabetes Management?
Description: The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice? Credit available for this activity expires: 6/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001235?ecd=bdc_podcast_libsyn_mscpedu